KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 203 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,980,000 | +66.2% | 57,682 | +25.8% | 0.26% | +48.6% |
| Q1 2017 | $3,598,000 | +76.7% | 45,842 | +1.0% | 0.18% | +69.9% |
| Q4 2016 | $2,036,000 | -21.1% | 45,402 | -1.8% | 0.10% | -23.7% |
| Q3 2016 | $2,581,000 | +25.9% | 46,213 | +12.7% | 0.14% | +14.4% |
| Q2 2016 | $2,050,000 | +10.5% | 41,001 | +1.4% | 0.12% | +10.3% |
| Q1 2016 | $1,856,000 | -23.8% | 40,421 | +2.2% | 0.11% | -23.0% |
| Q4 2015 | $2,437,000 | +92.6% | 39,545 | +74.0% | 0.14% | +69.5% |
| Q3 2015 | $1,265,000 | – | 22,725 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |